Although uncommon, some people with cancer will develop granulomas, the clumps of immune cells that are a hallmark of…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) and the Foundation for Sarcoidosis Research (FSR) have recognized…
Relative to the general population, people with sarcoidosis are at higher long-term risk of heart failure and other heart…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
People with sarcoidosis are being asked to donate blood samples and information related to their disease to help the…
People with sarcoidosis who have impaired lung function seem to be at greater risk for severe COVID-19Â disease, a…
A grant from the Foundation for Sarcoidosis Research (FSR) will fund the development of a new mouse model of…
Protalix BioTherapeutics and SarcoMed USA have entered into a non-binding agreement related to the development and commercialization of…
People with sarcoidosis-associated pulmonary hypertension who have reduced physical fitness or worse gas exchange capacity live significantly shorter times…